Cargando…

P16 (INK4a) gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysis

BACKGROUND: This meta‐analysis was conducted to investigate the diagnostic performance of P16 (INK4a) gene promoter methylation as a biomarker of non‐small cell lung cancer (NSCLC). METHODS: Two reviewers independently searched the Web of Science, PubMed, Cochrane, Embase, China National Knowledge I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuo, Lei, Sha, Sha, Huayu, Zhang, Du, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068431/ https://www.ncbi.nlm.nih.gov/pubmed/29927090 http://dx.doi.org/10.1111/1759-7714.12783

Ejemplares similares

Association between P(16INK4a) Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis
por: Gu, Jundong, et al.
Publicado: (2013)

MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta‐analysis
por: Chen, Bizheng, et al.
Publicado: (2021)

Promoter and histone methylation and p16(INK4A) gene expression in colon cancer
por: YORUKER, EBRU ESIN, et al.
Publicado: (2012)

Association between P16(INK4a) Promoter Methylation and HNSCC: A Meta-Analysis of 21 Published Studies
por: Shi, Hao, et al.
Publicado: (2015)

Association between P16(INK4a) Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies
por: Xiao, Xiyue, et al.
Publicado: (2016)

Low frequency of p16(INK4a) promoter methylation in mammary carcinomas as revealed by positive display of methylated sites
por: Lilischkis, R, et al.
Publicado: (2000)

Cigarette Smoking and p16(INK4α) Gene Promoter Hypermethylation in Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis
por: Zhang, Bo, et al.
Publicado: (2011)

Methylation of the Suppressor Gene p16INK4a: Mechanism and Consequences
por: Tramontano, Alfonso, et al.
Publicado: (2020)

The blues of P(16)INK(4a): Aberrant promoter methylation and association with colorectal cancer in the Kashmir valley
por: SAMEER, A. SYED, et al.
Publicado: (2012)

Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
por: Ren, Yu, et al.
Publicado: (2017)

Gene Expression Status and Methylation Pattern in Promoter of P15INK4b and P16INK4a in Cord Blood CD34(+) Stem Cells
por: Azad, Mehdi, et al.
Publicado: (2013)

Role of p14(ARF) and p15(INK4B) promoter methylation in patients with lung cancer: a systematic meta-analysis
por: Yang, Xinmei, et al.
Publicado: (2016)

Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
por: Khazaei, Sedigheh, et al.
Publicado: (2016)

Hypermethylation of p16(INK4a) in Korean Non-small Cell Lung Cancer Patients
por: Hong, Young-Seoub, et al.
Publicado: (2007)

Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta‐analysis update
por: Zhou, Xiaoxi, et al.
Publicado: (2021)

DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours
por: Woodcock, D M, et al.
Publicado: (1999)

The relationship between P16(INK4A) and TP53 promoter methylation and the risk and prognosis in patients with oesophageal cancer in Thailand
por: Poosari, Arisara, et al.
Publicado: (2022)

Role of quantitative p16(INK4A) mRNA assay and digital reading of p16(INK4A) immunostained sections in diagnosis of cervical intraepithelial neoplasia
por: Vasiljević, Nataša, et al.
Publicado: (2017)

Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR
por: Lee, Jae Jun, et al.
Publicado: (2012)

Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions
por: Klump, B, et al.
Publicado: (2003)

p16INK4a in cellular senescence
por: Simboeck, Elisabeth, et al.
Publicado: (2013)

p16(INK4a) Expression in Porokeratosis
por: Uryu, Miki, et al.
Publicado: (2017)

Quantitative assessment of aberrant P16(INK4a) methylation in ovarian cancer: a meta-analysis based on literature and TCGA datasets
por: Ruan, Jie, et al.
Publicado: (2018)

The effects of transferring tumor suppressor gene p16(INK4A) to p16(INK4A)-deleted cancer cells*
por: Lee, Kye Young, et al.
Publicado: (1999)

Expression of p16(INK) (4a) is a biomarker of chondrocyte aging but does not cause osteoarthritis
por: Diekman, Brian O., et al.
Publicado: (2018)

APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta‐analysis
por: Liu, Fang, et al.
Publicado: (2021)

Senescence promotes in vivo reprogramming through p16(INK) (4a) and IL‐6
por: Mosteiro, Lluc, et al.
Publicado: (2017)

Aberrant DNA methylation of the p16(INK4a) gene in plasma DNA of breast cancer patients
por: Silva, J M, et al.
Publicado: (1999)

c-JUN prevents methylation of p16INK4a (and Cdk6): the villain turned bodyguard
por: Kollmann, Karoline, et al.
Publicado: (2011)

Detection of Aberrant p16(INK4A) Methylation in Sera of Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Chu, Hyung Jun, et al.
Publicado: (2004)

CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16(INK4a)
por: Du, Wenqi, et al.
Publicado: (2019)

Detection of methylation in the CpG islands of the p16INK4A, RASSF 1A and methylguanine methyltransferase gene promoters in pancreatic adenocarcinoma
por: Paikos, D, et al.
Publicado: (2009)

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
por: Anglim, Paul P, et al.
Publicado: (2008)

CDK6 Degradation Is Counteracted by p16(INK4A) and p18(INK4C) in AML
por: Schmalzbauer, Belinda S., et al.
Publicado: (2022)

Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16(INK4a)
por: Shachar, Shlomit S, et al.
Publicado: (2020)

Aberrant p16INK4A methylation: Relation to viral related chronic liver disease and hepatocellular carcinoma
por: El-Mougy, Fatma A., et al.
Publicado: (2014)

p16(INK4A) Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
por: Al-Ansari, M M, et al.
Publicado: (2013)

p16(INK4A) Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
por: Al-Ansari, M M, et al.
Publicado: (2013)

MZF1 mediates oncogene-induced senescence by promoting the transcription of p16(INK4A)
por: Wu, Dan, et al.
Publicado: (2022)

Prognostic Value of Overexpressed p16(INK4a) in Vulvar Cancer: A Meta-Analysis
por: Cao, Hanyu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ia5sqbgkblibiouar7iikqfi5n